Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Cognition in Schizophrenia
NCT00488163Phase 4Completed
- Sponsor
- Research Foundation for Mental Hygiene
- Start
- Jan 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine in schizophrenia, sponsored by Research Foundation for Mental Hygiene. Started Jan 2005; status: completed.
02
Drugs
atomoxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00488163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488163.